Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
March 31, 2024 19:00 ET
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company...
キュレイティブ・バイオテクノロジー (Curative Biotechnology, Inc.)、テレサ・ヒー博士 (Dr. Theresa Heah) を取締役会に指名することを発表
March 31, 2024 19:00 ET
|
Curative Biotechnology, Inc.
フロリダ州パームビーチおよび東京発, April 01, 2024 (GLOBE NEWSWIRE) -- 変性眼疾患の新しい治療法に焦点を当てた開発段階の生物医学企業であるキュレイティブ・バイオテクノロジー (OTC: CUBT) (「キュレイティブ・バイオテック」または「同社」)...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
March 22, 2024 09:45 ET
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
January 08, 2024 09:45 ET
|
Curative Biotechnology, Inc.
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative...
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
October 31, 2023 09:45 ET
|
Curative Biotechnology, Inc.
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology...
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
June 06, 2023 09:50 ET
|
Curative Biotechnology, Inc.
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
May 24, 2023 10:12 ET
|
Curative Biotechnology, Inc.
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or...
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
January 05, 2023 07:50 ET
|
Curative Biotechnology, Inc.
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
September 27, 2022 07:00 ET
|
Curative Biotechnology, Inc.
Boca Raton, FL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
June 16, 2022 09:50 ET
|
Curative Biotechnology, Inc.
Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...